Literature DB >> 11688573

Leiomyosarcoma of the paratesticular region: a clinicopathologic study.

C Fisher1, J R Goldblum, J I Epstein, E Montgomery.   

Abstract

The behavior of leiomyosarcoma (LMS) is site related, but there are limited data on such tumors presenting in the paratesticular region. Cases diagnosed as LMS of the paratesticular region from the files of three institutions were reviewed. Immunohistochemistry was performed in cases with available blocks, and follow-up information was obtained. From 31 cases originally diagnosed as LMS, 24 were retained after review. These were from men aged 34-86 years (mean 62 years; median 64 years) and involved the testicular tunica (10), spermatic cord (10), scrotal subcutis and dartos muscles (1 each), and the epididymis (1). Tumors ranged in size from 2-9 cm (mean 5 cm; median 4 cm). On immunohistochemical staining they expressed muscle-specific actin (13 of 14), smooth muscle actin (10 of 10), desmin (16 of 17), and CD34 (3 of 9); all of the latter three were strongly desmin-positive. Focal reactivity for cytokeratin (3 of 8) and S-100 protein (1 of 8) was seen. Follow-up information was available in 14 patients. Four (29%) had recurrences, in one case four times. Metastases to lymph nodes, lungs, or liver were seen in four patients (29%), of whom two had prior recurrences. Ten were alive with no evidence of disease (ANED), and four were dead of disease (DOD). Comparing outcome with tumor grade, all seven patients with grade 1 tumors (of whom two had recurrences) and all three with grade 2 tumors were ANED, whereas all four patients with grade 3 tumors were DOD. In summary, paratesticular LMSs are rare neoplasms. The majority in this site are low-grade, although high-grade lesions behave aggressively.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11688573     DOI: 10.1097/00000478-200109000-00004

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  22 in total

1.  A rare case: paratesticular leiomyosarcoma.

Authors:  Orcun Celik; Gonca Unlu
Journal:  Asian J Androl       Date:  2013-07-29       Impact factor: 3.285

2.  Paratesticular sarcomas: two cases with different evolutions.

Authors:  Margarida Matias; Miguel Carvalho; Luisa Xavier; José Alberto Teixeira
Journal:  BMJ Case Rep       Date:  2014-08-21

3.  Complex multilocular cystic lesion of rete testis, accompanied by smooth muscle hyperplasia, mimicking intratesticular Leydig cell neoplasm.

Authors:  Eduard Fridman; Josef Skarda; Efrat Ofek-Moravsky; Mario Cordoba
Journal:  Virchows Arch       Date:  2005-10-19       Impact factor: 4.064

4.  A rare cause of a scrotal mass: primary leiomyosarcoma of epididymis.

Authors:  Maher Mechri; Samir Ghozzi; Ramzi Khiari; Fethi Bougrine; Ammar Bouziani; Nawfel Benrais
Journal:  BMJ Case Rep       Date:  2009-02-26

5.  Leiomyosarcoma of the epididymis: 2 cases and review of the literature.

Authors:  Victor T H Yuen; Shane D Kirby; Young Chi Woo
Journal:  Can Urol Assoc J       Date:  2011-12       Impact factor: 1.862

6.  Imaging features of a huge spermatic cord leiomyosarcoma: Review of the literature.

Authors:  Irene Kyratzi; Evangelos Lolis; Eleni Antypa; Maria Alexandra Lianou; Demetrios Exarhos
Journal:  World J Radiol       Date:  2011-04-28

Review 7.  Morphological approach to tumours of the testis and paratestis.

Authors:  Robert E Emerson; Thomas M Ulbright
Journal:  J Clin Pathol       Date:  2007-02-16       Impact factor: 3.411

8.  Paratesticular sarcomas: our case series.

Authors:  Ülkü Küçük; Ümit Bayol; Emel Ebru Pala; Özlem Akman; Rauf Taner Divrik
Journal:  Turk J Urol       Date:  2013-06

9.  Histopathological Trends of Testicular Neoplasm: An Experience over a Decade in a Tertiary Care Centre in the Malwa Belt of Central India.

Authors:  Preeti Rihal Chakrabarti; Shilpi Dosi; Amit Varma; Priyanka Kiyawat; Gaurav Khare; Sandeep Matreja
Journal:  J Clin Diagn Res       Date:  2016-06-01

10.  A case of paratesticular leiomyosarcoma successfully treated with orchiectomy and chemotherapy.

Authors:  Bong Suk Ko; Nae Yu Kim; Ah Jung Ryu; Dong Soon Kim; Soo Jung Gong; Dae Kyung Kim; Hyun Jin Son; Jung-Ae Lee
Journal:  Cancer Res Treat       Date:  2012-09-30       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.